Skip to main content
. 2021 Nov;32(11):2933–2947. doi: 10.1681/ASN.2021040548

Table 6.

Baseline characteristics of donors who developed ESKD

Characteristics All donors with ESKD (n=43) BMI <30 kg/m2 (n=31) BMI 30.0-34.9 kg/m2 (n=8) BMI ≥35 kg/m2 (n=4) P Value
Age (yrs) 41 (30, 50) 41 (27, 43) 47 (40, 52) 47 (34, 51) 0.22
Male 22 (51.2) 16 (51.6) 5 (62.5) 1 (25.0) 0.55
Race/ethnicity 1.00
 Non-Hispanic White 34 (79.1) 23 (74.2) 7 (87.5) 4 (100.0)
 Non-Hispanic Black 5 (11.6) 4 (12.9) 1 (12.5) 0 (0.0)
 Hispanic 1 (2.3) 1 (3.2) 0 (0.0) 0 (0.0)
 Non-Hispanic Asian 1 (2.3) 1 (3.2) 0 (0.0) 0 (0.0)
 Other 2 (4.7) 2 (6.5) 0 (0.0) 0 (0.0)
Related to recipient 40 (93.0) 30 (96.8) 6 (75.0) 4 (100.0) 0.10
1st degree relative with hypertension 22 (56.4) 16 (57.1) 4 (57.1) 2 (50.0) 1.00
1st degree relative with diabetes 14 (35.0) 10 (35.7) 2 (25.0) 2 (50.0) 0.67
1st degree relative with kidney disease 33 (76.7) 26 (83.9) 5 (62.5) 2 (50.0) 0.18
1st degree relative with heart disease 14 (36.8) 12 (44.4) 1 (14.3) 1 (25.0) 0.43
BMI (kg/m2) 27.8 (24.1, 30.7) 25 (23.6, 28) 31.5 (30.9, 32.8) 36.3 (35.8, 39.0) <0.001
Systolic BP (mmHg) 123 (114, 130) 120 (113, 129) 124 (119, 130) 130 (126, 133) 0.14
Diastolic BP (mmHg) 78 (71, 82) 77 (71, 80) 78 (70, 83) 84 (81, 85) 0.09
Smoking 25 (64.1) 18 (62.1) 4 (66.7) 3 (75) 1.00
Total cholesterol (mg/dl) 205 (175, 215) 201 (174, 208) 232 (211, 252) 171 (171, 171) 0.06
LDL (mg/dl) 91 (47, 161) 69 (47, 91) 161 (161, 161) 0.22
HDL (mg/dl) 47 (38, 56) 44 (35, 53) 50 (41, 59) 0.44
Triglyceride (mg/dl) 140 (90, 195) 172 (105, 281) 137 (101, 165) 85 (56, 114) 0.27
Fasting glucose (mg/dl) 92 (84, 104) 92 (82, 103) 94 (84, 113) 90 (68, 96) 0.51
Serum creatinine (mg/dl) 1.0 (0.8, 1.1) 1.0 (0.8, 1.1) 1.1 (1.0, 1.2) 1.0 (0.8, 1.1) 0.22
eGFR (ml/min per 1.73m2) 83 (76, 104) 92 (79, 107) 82 (71, 85) 73 (67, 99) 0.14
Donation to end of follow-up (year) 34 (21, 39) 36 (20, 39) 26 (20, 30) 30 (26, 37) 0.11

Values are in frequency and % for categorical variables and median (IQR) for continuous variables.